Brought to you by:
LINC 2024: C-GUARDIANS data represent lowest event rates in published trials of CAS, TCAR and CEA
New data from the C-GUARDIANS pivotal investigational device exemption (IDE) trial support consideration of carotid artery stenting (CAS) with the CGuard embolic prevention stent system (EPS; InspireMD) as a “frontline therapeutic option for appropriate patients being considered for carotid revascularisation”.…
PAD guideline update from ACC, AHA and others centers multispecialty care
New multisociety clinical practice guidelines for the management of lower extremity peripheral arterial disease (PAD) have been published online in the Journal of the American College of Cardiology (JACC). One of the document’s key takeaway messages is that care for…
We are not ‘and vascular’: SVS set to launch ambitious new phase in branding campaign
SVS secretary details the spirit and the cause behind the next phase of the Society’s branding campaign aimed at helping vascular surgery become an instantly recognizable specialty inside and outside of the hospital. “We are not going to apologize for…
Studies highlight need for tailored treatment options for women with peripheral arterial disease
New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral arterial disease (PAD), including endovascular therapy and revascularisation. The data were presented recently at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024…
‘We need to continue to be deliberate’: Dedicated society for women vascular surgeons formed
The inaugural president spoke to Vascular Specialist about the newly formed International Society for Women Vascular Surgeons ahead of this year’s Women’s Vascular Summit (May 3–4) in Chicago, outlining its genesis and goals, as well as some of the highlights…
‘Who let a vascular surgeon in the room?’: Leadership in the face of turf battles in vascular disease treatment
Leading vascular surgeons from across the globe contributed pearls of wisdom on how to go about tackling inevitable turf battles from other specialties practicing in the vascular disease space during a leadership challenges session staged by the World Federation of…
The top 10 most popular Vascular Specialist stories of April 2024
In April, the most read stories from Vascular Specialist include new research on Chat generative pre-trained transformer (GPT) technology and its application within vascular surgery and training; SVS Vice President candidates are announced; a guest editorial on how open access…
US FDA approves expanded indication for Gore Excluder conformable device
Gore has announced US Food and Drug Administration (FDA) approval of an expanded indication for the Gore Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis. The device is now indicated for patients with aortic neck angulation ≤90° and a minimum length…
JVS-VL papers go under the microscope
On the final day of the 2024 International Vein Congress (April 18–20) in Miami, Florida, Joseph P. Hart, MD, associate professor of surgery and radiology at Medical College of Wisconsin in Milwaukee, Wisconsin, Andrea P. Munive-Gnecco, MD, from Bogotá, Colombia,…
New randomised data show cyanoacrylate glue performs strongly on patient satisfaction
Patients undergoing cyanoacrylate glue closure for superficial venous disease reported higher periprocedural satisfaction than those who were treated via surgical stripping, data from a pair of randomised controlled trials (RCTs) assessing the VenaSeal system (Medtronic) reveal. The modality also showed…